5608-98-0

Basic information

• Product Name: 1-OXA-4-THIA-8-AZA-SPIRO[4.5]DECANE
• Synonyms: 1-OXA-4-THIA-8-AZA-SPIRO[4.5]DECANE
• CAS NO: 5608-98-0
• Molecular Formula: C7H13NOS
• Molecular Weight: 159.24922
• Mol File: 5608-98-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: °Cat760mmHg
• Flash Point: °C
• Appearance: /
• Density: 1.253g/cm³
• Refractive Index: 1.619
• CAS DataBase Reference: 1-OXA-4-THIA-8-AZA-SPIRO[4.5]DECANE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-OXA-4-THIA-8-AZA-SPIRO[4.5]DECANE(5608-98-0)
• EPA Substance Registry System: 1-OXA-4-THIA-8-AZA-SPIRO[4.5]DECANE(5608-98-0)

Safety Data

• Hazardous Substances Data: 5608-98-0(Hazardous Substances Data)

Usage

Molecular structure

A unique spirocyclic structure with a heterocyclic ring system containing one oxygen, one sulfur, and one nitrogen atom, along with a spiro bridge connecting two cyclohexane rings.

Potential applications

Medicinal chemistry and drug development due to its complex structure and potential pharmacological properties.

Spirocyclic framework

Provides structural diversity and unique biological activities, making it an interesting target for synthetic and medicinal chemistry research.

Building block

Has the potential to serve as a building block for the synthesis of novel drug candidates and bioactive compounds.

Further research

Exploration of its properties may reveal its potential for various applications in the field of chemistry and pharmaceuticals.

InChI:InChI=1/C30H30N2O5S/c1-36-28-18-17-23(21-29(28)37-2)19-20-31-30(33)26-15-9-10-16-27(26)32(22-24-11-5-3-6-12-24)38(34,35)25-13-7-4-8-14-25/h3-18,21H,19-20,22H2,1-2H3,(H,31,33)

Upstream product

• 41979-39-9 4-piperidone hydrochloride 
• 60-24-2 2-hydroxyethanethiol 
• 40064-34-4 piperidine-4,4-diol hydrochloride 

Relevant articles and documents

Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity

The inclusion of an azaspiroketal Mannich base in the membrane targeting antitubercular 6-methoxy-1-n-octyl-1H-indole scaffold resulted in analogs with improved selectivity and submicromolar activity against Mycobacterium tuberculosis H37Rv. The potency enhancing properties of the spiro-fused ring motif was affirmed by SAR and validated in a mouse model of tuberculosis. As expected for membrane inserting agents, the indolyl azaspiroketal Mannich bases perturbed phospholipid vesicles, permeabilized bacterial cells, and induced the mycobacterial cell envelope stress reporter promoter piniBAC. Surprisingly, their membrane disruptive effects did not appear to be associated with bacterial membrane depolarization. This profile was not uniquely associated with azaspiroketal Mannich bases but was characteristic of indolyl Mannich bases as a class. Whereas resistant mycobacteria could not be isolated for a less potent indolyl Mannich base, the more potent azaspiroketal analog displayed low spontaneous resistance mutation frequency of 10-8/CFU. This may indicate involvement of an additional envelope-related target in its mechanism of action.

4-[[3-[α-Aminobenzyl]phenyl]methyl]morpholine and 4-[-[3-benzoylphenyl]ethyl]morpholine

N-{2, 3- and 4-[R1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines, useful as anti-inflammatory agents, are prepared either by reduction of 2-, 3- or 4-[R1 -(phenyl)-CO]-phenyl-lower-alkanoylamines, which are also useful as anti-inflammatory agents; by benzoylating a phenyl-lower-alkylamine; by reaction of a 2-, 3- or 4-lithiophenyl-lower-alkylamine with a R1 -(phenyl)-carboxaldehyde, a R1 -(phenyl)-lower-alkyl ketone or a R1 -(phenyl)-carbonitrile; by reaction of a 2-, 3- or 4-[R1 -(phenyl)-CO]-phenyl-lower-alkyl tosylate with an appropriate amine; or by transformations involving manipulations of a carbonyl or carbinol group.